What are the major opportunities in the Valley Fever market? What are the strategies for the Valley Fever market?

For detailed insights on the major opportunities and strategies in the Valley Fever market, Read More

How does the Valley Fever market relate to the overall economy and other similar markets?

For detailed insights on Valley Fever's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Valley Fever industry?

For detailed insights on the mergers and acquisitions in the Valley Fever industry, Read More

What are the key dynamics influencing the Valley Fever market growth? SWOT analysis of the Valley Fever market.

For detailed insights on the key dynamics influencing the Valley Fever market growth and SWOT analysis of the Valley Fever industry, Read More

Valley Fever Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Valley Fever Market Report 2026

Name: Valley Fever Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Types Of Treatment (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment), By Site Of Infection (Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection), By End-Users (Human, Cattle, Sheep And Goats, Camel, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Valley Fever Market Overview

• Valley Fever market size has reached to $1.05 billion in 2025

• Expected to grow to $1.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%

• Growth Driver: Increasing Exposure To Fungus Spores Driving Infection Rates Due To Environmental And Human Activity Changes

• Market Trend: Innovative Vaccine Development Advancing Protection Against Fungal Infections

• North America was the largest region in 2025.

What Is Covered Under Valley Fever Market?

Valley fever, also called coccidioidomycosis, is a fungal infection that primarily affects the lungs and can cause symptoms such as cough, fever, fatigue, and chest pain, with some cases resulting in severe complications. It is caused by inhaling airborne spores of the coccidioides fungi, which are commonly present in dry, dusty soil and can become airborne when the soil is disturbed.

The main treatment types of valley fever are fluconazole, itraconazole, voriconazole, posaconazole, others. Fluconazole is an antifungal medication commonly used to treat fungal infections by inhibiting the growth of fungi. The various site of infection include skin, lungs, liver, bones, heart, brain, membranes that surround the brain and spinal cord, others. These are used by various end-users such as human, cattle, sheep and goats, camel, others.

Valley Fever Market Global Report 2026 Market Report bar graph

What Is The Valley Fever Market Size and Share 2026?

The valley fever market size has grown strongly in recent years. It will grow from $1.05 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to improved clinical recognition of fungal infections, availability of established antifungal medications, rising reported cases in endemic areas, increased diagnostic testing, expansion of infectious disease treatment centers.

What Is The Valley Fever Market Growth Forecast?

The valley fever market size is expected to see strong growth in the next few years. It will grow to $1.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to growing focus on rapid diagnostic tools, increasing investment in novel antifungal therapies, expansion of disease surveillance programs, rising awareness of climate-related disease spread, increasing demand for effective long-term treatment options. Major trends in the forecast period include increasing focus on early diagnosis and treatment, growing use of antifungal drug therapies, rising awareness in endemic regions, expansion of combination treatment approaches, increasing research into fungal disease management.

Book your 30 minutes free consultation with our research experts

Global Valley Fever Market Segmentation

1) By Types Of Treatment: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment

2) By Site Of Infection: Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection

3) By End-Users: Human, Cattle, Sheep And Goats, Camel, Other End-Users

Subsegments:

1) By Fluconazole Type: Oral Fluconazole, Intravenous Fluconazole

2) By Itraconazole Type: Capsule Itraconazole, Oral Solution Itraconazole

3) By Voriconazole Type: Oral Voriconazole, Intravenous Voriconazole

4) By Posaconazole Type: Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole

5) By Other Treatment Types: Combination Therapy, Adjunctive Therapy

What Are The Drivers Of The Valley Fever Market?

The rising exposure to fungus spores is expected to propel the valley fever market going forward. Fungus spores are microscopic reproductive units produced by fungi that can spread through air, water, or surfaces, enabling the fungus to grow and reproduce in new environments. The exposure to fungus spores is increasing due to deforestation and changing weather patterns, which disturb soil and promote spore release, resulting to a higher risk of infections such as valley fever, especially in arid regions where the coccidioides fungus thrives. Valley fever treatment helps patients exposed to fungal spores by reducing symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For instance, in September 2024, according to the International Society for Infectious Diseases, a US-based non-profit organization, each year, invasive fungal infections impact about 6.5 million individuals, resulting in nearly 3.8 million fatalities, of which approximately 2.5 million are directly attributed to these infections. Therefore, the rising exposure to fungus spores is driving the growth of the valley fever industry.

The rising healthcare facilities is expected to propel the growth of the valley fever market going forward. Healthcare facilities refer to the essential physical facilities, systems, and resources needed to provide effective healthcare services. Expanding healthcare facilities is due to advancements in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and enhanced healthcare delivery systems to improve patient outcomes and efficiency. Healthcare facilities support valley fever by providing early diagnosis, antifungal treatments, patient education, and ongoing care to manage symptoms and prevent complications. For instance, in July 2025, according to Eurostat, Luxembourg-based statistical office of the European Union, the EU recorded 511 hospital beds per 100,000 people in 2023, while Bulgaria reported the highest ratio in the region at 864 beds per 100,000 people. Therefore, the expanding healthcare infrastructure is driving the growth of the valley fever industry.

Key Players In The Global Valley Fever Market

Major companies operating in the valley fever market are Merck & Co Inc, Fresenius Kabi, Dr Reddys Laboratories, Mankind Pharma, Atom Pharma, Cerata Pharmaceuticals, Pfizer Inc, Novartis AG, Sanofi S A, GlaxoSmithKline plc, Bayer AG, Astellas Pharma Inc, Abbott Laboratories Inc, SCYNEXIS Inc, Leadiant Biosciences Inc, Amplyx Pharmaceuticals Inc, Johnson & Johnson, Bristol Myers Squibb, Gilead Sciences Inc, Viatris Inc, Teva Pharmaceuticals USA Inc

Global Valley Fever Market Trends and Insights

Major companies operating in the valley fever market are focusing on developing innovative vaccines for valley fever to address the rising threat of fungal infections. Valley fever vaccines aim to protect people by leveraging advanced science and manufacturing techniques, enhancing public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a US-based pet pharmaceutical company, received a contract worth up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID), a US-based government agency to develop a human Valley Fever vaccine. The funding will support additional manufacturing, formulation, extensive safety testing, and a Phase 1 clinical trial, aiming to deliver the first vaccine to prevent a serious systemic fungal infection.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

North America was the largest region in the valley fever market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Valley Fever Market?

The valley fever market consists of sales of antifungal medications and steroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Valley Fever Market Report 2026?

The valley fever market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the valley fever industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Valley Fever Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.1 billion
Revenue Forecast In 2035	$1.35 billion
Growth Rate	CAGR of 5.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Types Of Treatment, Site Of Infection, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co Inc, Fresenius Kabi, Dr Reddys Laboratories, Mankind Pharma, Atom Pharma, Cerata Pharmaceuticals, Pfizer Inc, Novartis AG, Sanofi S A, GlaxoSmithKline plc, Bayer AG, Astellas Pharma Inc, Abbott Laboratories Inc, SCYNEXIS Inc, Leadiant Biosciences Inc, Amplyx Pharmaceuticals Inc, Johnson & Johnson, Bristol Myers Squibb, Gilead Sciences Inc, Viatris Inc, Teva Pharmaceuticals USA Inc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Valley Fever Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Valley Fever Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Valley Fever Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Valley Fever Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Focus On Early Diagnosis And Treatment

4.2.2 Growing Use Of Antifungal Drug Therapies

4.2.3 Rising Awareness In Endemic Regions

4.2.4 Expansion Of Combination Treatment Approaches

4.2.5 Increasing Research Into Fungal Disease Management

5. Valley Fever Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Infectious Disease Clinics

5.3 Diagnostic Laboratories

5.4 Public Health Agencies

5.5 Veterinary Clinics

6. Valley Fever Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Valley Fever Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Valley Fever PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Valley Fever Market Size, Comparisons And Growth Rate Analysis

7.3. Global Valley Fever Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Valley Fever Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Valley Fever Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Valley Fever Market Segmentation

9.1. Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others Types Of Treatment

9.2. Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Skin, Lungs, Liver, Bones, Heart, Brain, Membranes That Surround The Brain And Spinal Cord, Other Sites Of Infection

9.3. Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human, Cattle, Sheep And Goats, Camel, Other End-Users

9.4. Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Fluconazole, Intravenous Fluconazole

9.5. Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Capsule Itraconazole, Oral Solution Itraconazole

9.6. Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Voriconazole, Intravenous Voriconazole

9.7. Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Suspension Posaconazole, Delayed-Release Tablets Posaconazole, Intravenous Posaconazole

9.8. Global Valley Fever Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Combination Therapy, Adjunctive Therapy

10. Valley Fever Market Regional And Country Analysis

10.1. Global Valley Fever Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Valley Fever Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Valley Fever Market

11.1. Asia-Pacific Valley Fever Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Valley Fever Market

12.1. China Valley Fever Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Valley Fever Market

13.1. India Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Valley Fever Market

14.1. Japan Valley Fever Market Overview

14.2. Japan Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Valley Fever Market

15.1. Australia Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Valley Fever Market

16.1. Indonesia Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Valley Fever Market

17.1. South Korea Valley Fever Market Overview

17.2. South Korea Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Valley Fever Market

18.1. Taiwan Valley Fever Market Overview

18.2. Taiwan Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Valley Fever Market

19.1. South East Asia Valley Fever Market Overview

19.2. South East Asia Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Valley Fever Market

20.1. Western Europe Valley Fever Market Overview

20.2. Western Europe Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Valley Fever Market

21.1. UK Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Valley Fever Market

22.1. Germany Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Valley Fever Market

23.1. France Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Valley Fever Market

24.1. Italy Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Valley Fever Market

25.1. Spain Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Valley Fever Market

26.1. Eastern Europe Valley Fever Market Overview

26.2. Eastern Europe Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Valley Fever Market

27.1. Russia Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Valley Fever Market

28.1. North America Valley Fever Market Overview

28.2. North America Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Valley Fever Market

29.1. USA Valley Fever Market Overview

29.2. USA Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Valley Fever Market

30.1. Canada Valley Fever Market Overview

30.2. Canada Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Valley Fever Market

31.1. South America Valley Fever Market Overview

31.2. South America Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Valley Fever Market

32.1. Brazil Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Valley Fever Market

33.1. Middle East Valley Fever Market Overview

33.2. Middle East Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Valley Fever Market

34.1. Africa Valley Fever Market Overview

34.2. Africa Valley Fever Market, Segmentation By Types Of Treatment, Segmentation By Site Of Infection, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Valley Fever Market Regulatory and Investment Landscape

36. Valley Fever Market Competitive Landscape And Company Profiles

36.1. Valley Fever Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Valley Fever Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Valley Fever Market Company Profiles

36.3.1. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Dr Reddys Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Atom Pharma Overview, Products and Services, Strategy and Financial Analysis

37. Valley Fever Market Other Major And Innovative Companies

Cerata Pharmaceuticals, Pfizer Inc, Novartis AG, Sanofi S A, GlaxoSmithKline plc, Bayer AG, Astellas Pharma Inc, Abbott Laboratories Inc, SCYNEXIS Inc, Leadiant Biosciences Inc, Amplyx Pharmaceuticals Inc, Johnson & Johnson, Bristol Myers Squibb, Gilead Sciences Inc, Viatris Inc

38. Global Valley Fever Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Valley Fever Market

40. Valley Fever Market High Potential Countries, Segments and Strategies

40.1 Valley Fever Market In 2030 - Countries Offering Most New Opportunities

40.2 Valley Fever Market In 2030 - Segments Offering Most New Opportunities

40.3 Valley Fever Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Valley Fever Market, Overview Of Key Products - Product Examples

Table 2: Global Valley Fever Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Valley Fever Market, Supply Chain Analysis

Table 4: Global Valley Fever Market, Major Raw Material Providers

Table 5: Global Valley Fever Market, Major Resource Providers

Table 6: Global Valley Fever Market, Major Manufacturers (Suppliers)

Table 7: Global Valley Fever Market, Major Distributors And Channel Partners

Table 8: Global Valley Fever Market, Key Technologies & Future Trends

Table 9: Global Valley Fever Market, Major Trends

Table 10: Global Valley Fever Market, Major End Users

Table 11: Global Valley Fever Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Valley Fever Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Valley Fever Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Valley Fever Market - TAM, US$ Billion, 2025

Table 15: Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Valley Fever Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Valley Fever Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Valley Fever Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Valley Fever Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Valley Fever Market - Company Scoring Matrix

Table 99: Merck & Co Inc Financial Performance

Table 100: Fresenius Kabi Financial Performance

Table 101: Dr Reddys Laboratories Financial Performance

Table 102: Mankind Pharma Financial Performance

Table 103: Atom Pharma Financial Performance

Table 104: Global Valley Fever Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Valley Fever Market, Competitive Dashboard

Table 106: Global Valley Fever Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By Types Of Treatment, 2025 – 2030

Table 108: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By Site Of Infection, 2025 – 2030

Table 109: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

Figure 1: Global Valley Fever Market, Overview Of Key Products - Product Examples

Figure 2: Global Valley Fever Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Valley Fever Market, Supply Chain Analysis

Figure 4: Global Valley Fever Market, Major Raw Material Providers

Figure 5: Global Valley Fever Market, Major Resource Providers

Figure 6: Global Valley Fever Market, Major Manufacturers (Suppliers)

Figure 7: Global Valley Fever Market, Major Distributors And Channel Partners

Figure 8: Global Valley Fever Market, Key Technologies & Future Trends

Figure 9: Global Valley Fever Market, Major Trends

Figure 10: Global Valley Fever Market, Major End Users

Figure 11: Global Valley Fever Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Valley Fever Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Valley Fever Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Valley Fever Market - TAM, US$ Billion, 2025

Figure 15: Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Valley Fever Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Valley Fever Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Valley Fever Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Valley Fever Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Valley Fever Market - Company Scoring Matrix

Figure 99: Merck & Co Inc Financial Performance

Figure 100: Fresenius Kabi Financial Performance

Figure 101: Dr Reddys Laboratories Financial Performance

Figure 102: Mankind Pharma Financial Performance

Figure 103: Atom Pharma Financial Performance

Figure 104: Global Valley Fever Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Valley Fever Market, Competitive Dashboard

Figure 106: Global Valley Fever Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By Types Of Treatment, 2025 – 2030

Figure 108: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By Site Of Infection, 2025 – 2030

Figure 109: Global, Valley Fever Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Cyclic Heavy Menstrual Bleeding Market Report 2026 - Global Outlook – By Treatment Type (Pharmaceuticals, Surgical Or Procedural, Medical Devices), By Etiology (Hormonal Disorders, Structural Abnormalities, Coagulopathie...

Alcohol Excipients Market Report 2026 - Global Outlook – By Type (Sorbitol, Mannitol, Propylene Glycol, Glycerin, Other Types), By Application (Pharmaceutical, Personal Care, Cosmetics, Other Applications), By Distributi...

Influenza Diagnostic Market Report 2026 - Global Outlook – By Traditional Diagnostic Tests (Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests ), By Molecu...

High Flow Needle Sets Market Report 2026 - Global Outlook – By Product Type (High Flow Needle Sets, High Flow Winged (Butterfly) Needle Sets, High Flow Safety Needle Sets), By Gauge Size (18 Gauge High Flow Needle Sets, ...

Electrocautery Enhanced Delivery System Market Report 2026 - Global Outlook – By Product (Active Electrode, Dispersive Electrode), By Application (Cutting, Coagulating, Devitalization, Thermofusion), By End User (Hospita...

Biochips Market Report 2026 - Global Outlook – By Type (Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays), By Technology (Microarrays, Microfluidics), By Application (Drug Discove...

Automotive Stainless Steel Market Report 2026 - Global Outlook – By Tube Type (Straight Tubes, U-Bends, Coiled Tubes), By Manufacturing Method (Seamless Tubes, Welded Tubes), By Vehicle Type (Passenger Cars, Commercial V...

Frequently Asked Questions

How big is the Valley Fever Market?

The Valley Fever market was valued at $1.05 billion in 2025, increased to $1.1 billion in 2026, and is projected to reach $1.35 billion by 2030.

What is the Valley Fever market growth?

The global Valley Fever market is expected to grow at a CAGR of 5.1% from 2026 to 2035 to reach $1.35 billion by 2035.

Who are the key players in Valley Fever market?

Some Key Players in the Valley Fever market Include, Merck & Co Inc, Fresenius Kabi, Dr Reddys Laboratories, Mankind Pharma, Atom Pharma, Cerata Pharmaceuticals, Pfizer Inc, Novartis AG, Sanofi S A, GlaxoSmithKline plc, Bayer AG, Astellas Pharma Inc, Abbott Laboratories Inc, SCYNEXIS Inc, Leadiant Biosciences Inc, Amplyx Pharmaceuticals Inc, Johnson & Johnson, Bristol Myers Squibb, Gilead Sciences Inc, Viatris Inc, Teva Pharmaceuticals USA Inc .

What is the anticipated growth trend for the Valley Fever market?

Major trend in this market includes: Innovative Vaccine Development Advancing Protection Against Fungal Infections. For further insights on this market. request a sample here

Which region has the most growth potential in the Valley Fever market?

North America was the largest region in the valley fever market in 2025. The regions covered in the valley fever market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.